Partnerships in Innovation

We seek partners for targeted, high-impact projects:

• Human-Robot Teaming & Humanoids Co-develop adaptive systems for safe human collaboration in dynamic environments (e.g., exploration, manufacturing).
• Swarm & Mobile Robotics Build coordinated fleets for environmental monitoring, disaster response, or precision agriculture using multi-agent AI.
• Soft Robotics & Delicate Tasks Advance flexible grippers and manipulators for healthcare, agriculture, or unstructured handling.
• Autonomous Systems & AI Integration Enhance perception, learning,and decision-making with drone swarms or simulation-to-real transfer.
• Open-Source Contributions Joint development on ROS-based platforms for affordable, customizable robots.

• Start with aligned goals and a proof-of-concept.
• Flexible models: Joint R&D, technology licensing, integration partnerships, or ecosystem contributions.
• Committed to open innovation and long-term success.

• Proprietary Expertise: Our nanoparticle technologies— including lipid, polymer, and gold-based systems—enable precise targeting, controlled release, and minimal off-target effects, as seen in recent advancements for breast cancer and atherosclerosis treatments.
• Cutting-Edge Techniques: Leverage our innovations in active/passive targeting, pH-sensitive delivery, and integration with emerging nanomedicines like exosomes and dendrimers for superior bioavailability.
• Mutual Growth: Joint R&D accelerates regulatory approvals, expands market access, and shares IP, drawing from 2025 trends in nanoparticle-driven therapies for enhanced precision in oncology and cardiology.
• Proven Impact: Collaborations yield scalable solutions with improved pharmacokinetics, reducing toxicity in diseases like hypertension, myocardial infarction, and various cancers.

We invite partners for high-impact projects in targeted drug delivery:

• Cancer Therapies : Co-develop nanoparticle systems for tumor-specific delivery, focusing on gold and liposomal carriers for chemotherapeutics. Target solid tumors like breast cancer with stimuli-responsive mechanisms to boost localized efficacy.
• Cardiovascular Disease: Interventions Partner on heart-targeted nanocarriers for conditions like atherosclerosis and hypertension, using polymer-based and biomimetic platelets for efficient drug release in cardiac tissues.
• Other Chronic Diseases: Explore applications in neurology, inflammation, or infectious diseases with versatile nanoparticles, incorporating inhalation or injectable formats for broad therapeutic reach.
• Platform Customization & Integration: Collaborate on tailoring our proprietary tech (e.g., sub-15 nm particles or DNA-based frameworks) with your payloads for personalized medicine.
• Clinical & Regulatory Pathways: Joint efforts in preclinical testing, scaling production, and navigating approvals for nanoparticle formulations.

• Phased Collaboration: Begin with feasibility studies, advance to co-prototyping, and culminate in clinical pilots.
• Flexible Models: IP sharing, licensing, joint ventures, or research alliances focused on ethical, sustainable nanomedicine.
• Innovation-Driven: Aligned with 2025 breakthroughs in nanoparticle engineering for reduced side effects and targeted precision.

Join us in transforming drug delivery. Contact our team to discuss tailored collaboration opportunities.